The mechanism of aberrant GH responses to TRH was indirectly evaluated in 7 patients with primary hypothyroidism. All patients showed GH response to TRH. When TRH was administered together with GHRH, the plasma GH response was much greater than after a single administration of TRH or GHRH (TRH+GHRH vs. TRH or GHRH: max. Δ GH, 16.4±3.2vs. 5.4±1.3 or 6.0±0.8μg/L; AUC, 1282.7±234.7vs. 384.0±95.0 or 441.8±66.2, both P <0.01). The combined administration of TRH and GHRH caused an additive, but not a synergistic, GH response. In contrast, 8 normal subjects showed neither any plasma GH response to TRH nor enhancement by TRH of GHRH-induced GH response following combined administration. It is concluded that the sites of action of TRH seemed to be different from GHRH in patients with primary hypothyroidism.
- Plasma GH
- Primary hypothyroidism
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism